1
/
of
0
FDA Drug Approval, N020121, FLONASE
FDA Drug Approval, N020121, FLONASE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 020121
Company: HALEON US HOLDINGS
Drug Name: FLONASE
Active Ingredients: FLUTICASONE PROPIONATE
Strength: SPRAY, METERED;NASAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
Company: HALEON US HOLDINGS
Drug Name: FLONASE
Active Ingredients: FLUTICASONE PROPIONATE
Strength: SPRAY, METERED;NASAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details